The United States Food and Drug Administration (FDA) rigorously evaluates and approves companies that produce treatments like GLP-1 receptor agonists. These medications are designed to help manage type 2 diabetes by boosting insulin production in the body and lowering glucagon release. The FDA approval process ensures that these medicines meet high